Effect of tamoxifen and raloxifene on the proliferative activity of the breast epithelium in premenopausal women
Carregando...
Data
2015
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Objectives: To compare the effects of tamoxifen and raloxifene on the proliferative activity of normal breast tissue in premenopausal women as
measured by Ki-67/MIB-1 expression.
Study design: A total of 48 women with benign breast nodules and a recommendation for surgical removal of the lesion took part in this study. They
were randomized to use tamoxifen or raloxifene for 22 days, after which they were submitted to surgery. During the surgical procedure, a 1-cm fragment of
normal breast tissue was removed to study Ki-67 expression.
Results: The mean percentage ratios between immunolabeled and non-labeled cells were 2.02 ± 1.09 and 3.13 ± 3.23 for the tamoxifen and raloxifene
groups, respectively. There was no statistically significant difference between the tamoxifen (n = 16) and raloxifene (n = 14) groups in relation to the immuno
histochemical analysis of Ki-67 (P = 0.205).
Conclusion: The results of this study showed no difference between tamoxifen and raloxifene with respect to the potential of these drugs to reduce
the proliferative activity of the normal breast epithelium in premenopausal women.
Descrição
Palavras-chave
Breast epithelium, Tamoxifen, Breast, Raloxifene, Ki-67, Premenopausal women
Citação
LUCATO, Miliana T. et al. Effect of tamoxifen and raloxifene on the proliferative activity of the breast epithelium in premenopausal women. Clinical Medicine Insights: oncology, London, v. 9, p. 25-30, 2015.